Detalhe da pesquisa
1.
Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.
Proc Natl Acad Sci U S A
; 120(32): e2216532120, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523561
2.
Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.
Curr Opin Oncol
; 26(3): 252-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24626127
3.
HPV-associated head and neck cancer: a virus-related cancer epidemic.
Lancet Oncol
; 11(8): 781-9, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20451455
4.
Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
Curr Opin Oncol
; 22(3): 206-11, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20216313
5.
Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer.
J Urol
; 182(1): 317-23, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447430
6.
New directions in the systemic treatment of metastatic thyroid cancer.
Oncology (Williston Park)
; 23(9): 768-75, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19777762
7.
Head and neck cancer: changing epidemiology, diagnosis, and treatment.
Mayo Clin Proc
; 83(4): 489-501, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18380996
8.
FDA analyses of survival in older adults with metastatic non-small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies.
Semin Oncol
; 45(4): 220-225, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30391014
9.
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.
Oral Oncol
; 82: 83-90, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909907
10.
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
J Clin Oncol
; 35(5): 490-497, 2017 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28029303
11.
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.
Mayo Clin Proc
; 91(3): 386-96, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26944243
12.
Evaluating Cancer Drugs in Patients With Central Nervous System Metastases.
JAMA Oncol
; 2021 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33856413
13.
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma.
Oral Oncol
; 53: 54-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26705063
14.
Cetuximab activity in dysplastic lesions of the upper aerodigestive tract.
Oral Oncol
; 53: 60-6, 2016 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686755
15.
Unusual Paraneoplastic Presentation of Cholangiocarcinoma.
Case Rep Med
; 2015: 806835, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26495003
16.
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.
Clin Cancer Res
; 21(1): 30-8, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564570
17.
Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.
Head Neck
; 36(12): 1747-53, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24174270
18.
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.
Thyroid
; 24(2): 232-40, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23721245
19.
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.
J Nucl Med
; 54(12): 2039-45, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101687
20.
Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer.
Cancer Med
; 2(3): 351-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23930212